ArticleCancers2026

Dihydroartemisinin Suppresses Hepatocellular Carcinoma Progression by Acting on KIF11 with PI3K/Akt Modulation.

Aina Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.